(Q34461570)

2 August 2017

Acetazolamide improves central sleep apnea in heart failure: a double-blind, prospective study (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

Shahrokh Javaheri

1

1 reference

PubMed ID

16239622

2 August 2017

language of work or name

English

0 references

publication date

20 October 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

2 August 2017

1 reference

2 August 2017

173

1 reference

2 August 2017

2

1 reference

2 August 2017

234-237

1 reference

Respiration and abnormal sleep in patients with congestive heart failure.

2 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Central apnea index decreases after prolonged treatment with acetazolamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Effect of Acetazolamide on Hypoxemia during Sleep at High Altitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Effect of ventilatory drive on carbon dioxide sensitivity below eupnea during sleep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Occult sleep-disordered breathing in stable congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Cheyne-Stokes respiration presenting as sleep apnea syndrome. Clinical and polysomnographic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

A mechanism of central sleep apnea in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Effects of domperidone and medroxyprogesterone acetate on ventilation in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Hypocapnia is not a predictor of central sleep apnea in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Crossing the threshold: implications for central sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Apnea-hypopnea threshold for CO2 in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Influence of pulmonary capillary wedge pressure on central apnea in heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200507-1035OC

10.1164/RCCM.200507-1035OC

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

16239622